Nestlé Baby Food Sample Fails Quality Test in India
India’s food safety regulator has initiated legal action against Nestlé India after a laboratory test found a sample of its infant follow-up formula did not meet the prescribed biotin requirement. The regulator has also opened separate cases over promotional claims made for two other infant nutrition products.
FSSAI Finds Biotin Non-Compliance
The Food Safety and Standards Authority of India (FSSAI) said a sample of Nestlé’s follow-up formula was found to be sub-standard with respect to biotin, also known as vitamin B7, during laboratory analysis.
The sample was sent for re-analysis, and the referral laboratory also found it non-conforming with the prescribed biotin requirement under India’s infant nutrition regulations.
FSSAI’s prescribed range for biotin in follow-up formula is 7.50–50 micrograms per 100 grams, or 1.60–10.60 micrograms per 100 kcal, according to the applicable regulatory standards.
Three Separate Cases Against Nestlé India
The regulator's action covers three infant nutrition products.
Two cases concern promotional claims associated with NAN Excella Pro Stage 1 and Lactogen Pro 1. FSSAI raised concerns about claims involving “5 HMOs” and whey protein for NAN Excella Pro Stage 1, while Lactogen Pro 1 was scrutinised over a claim describing its whey protein as easy to digest.
FSSAI said these promotional activities were considered contrary to provisions governing the promotion and advertising of infant foods in India.
The third case relates specifically to the laboratory finding involving the follow-up formula's biotin content.
Nestlé Says Its Products Comply With Regulations
Nestlé India has said that its products are fully compliant with applicable regulations and that it will continue working with FSSAI. The company has disputed the regulatory concerns surrounding its infant nutrition products.
The proceedings therefore remain a regulatory matter, and the FSSAI findings should not be interpreted as a final judicial determination of wrongdoing by the company.
Why Biotin Matters in Infant Nutrition
Biotin is a B-group vitamin involved in several metabolic processes in the body. Because infant formulas are regulated according to specified nutritional compositions, Indian food-safety rules prescribe permitted levels for nutrients including biotin.
FSSAI has previously issued directions revising and operationalising limits for nutrients such as biotin, iron, selenium and manganese in infant nutrition products.
What Happens Next?
FSSAI has filed three separate adjudication cases concerning the products. The proceedings will determine the regulatory consequences of the findings and alleged violations.
The development comes amid increased food-safety scrutiny in India, with regulators examining product quality as well as marketing and labelling practices across the food industry.
For parents, the current action concerns specific products and regulatory findings; it does not establish that every Nestlé infant nutrition product is unsafe.
About TVR
TVR: The Voice Of Reform is an independent digital news platform covering major developments across India and around the world.
Editorial Note
Our articles are prepared using publicly available information and verified reporting. We aim to present news accurately, independently and responsibly. Information may be updated as new facts emerge.
© 2026 TVR: The Voice Of Reform. All Rights Reserved.
- Get link
- X
- Other Apps
Labels
Breaking News Health- Get link
- X
- Other Apps
Comments